Chief Scientific Officer · MYRIAD GENETICS INC · Common Stock
Side
F
Value
$39K
Shares
8,288
Price
$4.66
Executed
Mar 14, 2026
Disclosed
Mar 16, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Mar 14 executedMar 16, 2026 disclosed
MYGN · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+1 / 25
$39K reported value · 2.5% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Muzzey Dale filed this Form 4 reporting a tax withholding of MYGN on Mar 14, 2026. It became public on Mar 16, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Scientific Officer
Muzzey Dalecik:0001922964
Issuer
MYRIAD GENETICS INCcik:0000899923
Revision history · 0
No field has changed since this record was first ingested.
